Previous 10 | Next 10 |
2023-08-17 11:18:38 ET More on Alcon Alcon Inc. ( ALC ) Q2 2023 Earnings Call Transcript Alcon: Lackluster Growth Given Its Valuation Alcon: The Steady Force Of 'Boring' Alcon Non-GAAP EPS of $0.69 beats by $0.04, revenue of $2.4B beats by $20M Al...
2023-08-16 11:29:09 ET Alcon Inc. (ALC) Q2 2023 Earnings Conference Call August 16, 2023, 8:00 AM ET Company Participants Daniel Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer C...
2023-08-15 17:35:30 ET Alcon ( NYSE: ALC ) is scheduled to announce Q2 earnings results on Wednesday, August 16th, after market close. The consensus EPS Estimate is $0.65 (+3.2% Y/Y) and the consensus Revenue Estimate is $2.38B (+8.2% Y/Y). Over the last 2 years, ALC ...
2023-08-15 16:49:01 ET More on Alcon Alcon: Lackluster Growth Given Its Valuation Alcon: The Steady Force Of 'Boring' Alcon rises as Baird upgrades after Q1 beat Alcon a buy at Mizuho on 'eyecare dominance' Alcon downgraded to sell at Societe Generale...
Second quarter 2023 sales of $2.4 billion, up 9%, or 12% constant currency (1) (cc) Second quarter 2023 diluted EPS of $0.34, up 13%, or up 34% cc; core diluted EPS (2) of $0.69 up 10%, or 19% cc Based on strong operational performance and improved outlook, Company...
2023-08-13 08:02:00 ET More on Cisco, Deere, etc. Compare metrics for CSCO to DE, HD, SNDL, TGT, WMT Walmart: The Bottom Could Fall Out If Inflation Levels Continue To Fall Home Depot: Long-Term Winner, With Room To Run Target estimates lowered at Barclays ah...
2023-08-12 11:15:00 ET Summary Lifecore Biomedical, a specialty contract development and manufacturing organization, benefits from secular tailwinds and has additional capacity coming online. The company's debt situation has been resolved by $150M in financing from their largest c...
2023-08-04 11:33:46 ET Algoma Central Corporation press release ( ALC:CA ): Q2 GAAP EPS of C$0.79. Revenues of C$202,406, a 10% increase compared to the same period in 2022. EBITDA of C$65,204 compared to C$61,412 for the same period in 2022. For further details see:...
2023-07-26 04:33:52 ET Summary Alcon stock is currently trading at over 30x earnings, which is considered high for a company not expected to deliver EPS above 20 - 25% in the next few years. Despite the high trading multiple, Alcon has a strong business model and is a leader in th...
2023-07-23 12:00:31 ET Soon after Johnson & Johnson ( NYSE: JNJ ) topped expectations with its Q2 2023 results last week, Baird came up with a report indicating brighter days for MedTech, mainly due to accelerating medical procedure volumes and a waning COVID impact in China. ...
News, Short Squeeze, Breakout and More Instantly...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Alcon Inc. (NYSE: ALC) traded at a new 52-week high today and are currently trading at $91.69. So far today, approximately 136.09k shares have been exchanged, as compared to an average 30-day volume of 907.93k shares. Alcon Inc., an eye care company, researches, develops, manufactur...